GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $556,000 | -3.3% | 12,775 | -3.3% | 0.00% | 0.0% |
| Q1 2022 | $575,000 | +6.7% | 13,205 | +7.9% | 0.00% | 0.0% |
| Q4 2021 | $539,000 | +25.6% | 12,235 | +8.9% | 0.00% | 0.0% |
| Q3 2021 | $429,000 | -4.0% | 11,230 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $447,000 | +23.8% | 11,230 | +10.9% | 0.00% | +50.0% |
| Q1 2021 | $361,000 | +720.5% | 10,130 | +737.2% | 0.00% | – |
| Q4 2020 | $44,000 | +41.9% | 1,210 | +45.8% | 0.00% | – |
| Q3 2020 | $31,000 | -99.8% | 830 | -99.8% | 0.00% | -100.0% |
| Q4 2019 | $16,700,000 | +19.3% | 355,407 | -17.5% | 0.10% | -2.0% |
| Q3 2019 | $14,000,000 | – | 430,734 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |